Skip to main content


Although chordoma is a rare disease, increasing number of cases of chordoma is expected to propel growth of the chordoma disease therapeutics market over the forecast period. For instance, the American Cancer Society estimated that around 3,600 new cases of bone cancer will be diagnosed, out of which 10% cases will be of chordoma, in the U.S., in 2020.